Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Scienture Holdings, Inc.
Report date May 27, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 10,867 |
Reported balance
After 2021-05-27 transaction · row 1
1 source rowRow 1 · 2021-05-27 · Disposition to issuer · Disposed 8,041 · Balance 10,867 F1: The shares were forfeited back to the Issuer as the reporting person discontinued service to the Issuer as of May 27, 2021, due to the vesting conditions pertaining to the award not having been achieved. Exempt under Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were forfeited back to the Issuer as the reporting person discontinued service to the Issuer as of May 27, 2021, due to the vesting conditions pertaining to the award not having been achieved. Exempt under Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2021 Filed Jun 2, 2021 20:45 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | Disposition to issuerCommon stock | 8,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-013438 · ownership.xml · nonDerivative · entry 1 Tenaerts Pamela · CIK 0001794913 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,867 F1 · kind: The shares were forfeited back to the Issuer as the reporting person discontinued service to the Issuer as of May 27, 2021, due to the vesting conditions pertaining to the award not having been achieved. Exempt under Rule 16b-3(e). F1 · shares: The shares were forfeited back to the Issuer as the reporting person discontinued service to the Issuer as of May 27, 2021, due to the vesting conditions pertaining to the award not having been achieved. Exempt under Rule 16b-3(e). Read SEC document |
| April 19, 2021 Filed Apr 20, 2021 20:35 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 10,721 | $5.13 | $54,998.73 |
DisclosureSEC source: 0001493152-21-009258 · ownership.xml · nonDerivative · entry 1 Tenaerts Pamela · CIK 0001794913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,908 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2021 and January 1 and April 1, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · balance_after: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 17:50 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | SaleCommon stock | 800 | $5.30 | $4,240.00 |
DisclosureSEC source: 0001493152-20-023735 · ownership.xml · nonDerivative · entry 1 Tenaerts Pamela · CIK 0001794913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,187 F1 · shares: The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the December 2020 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 00:05 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantCommon stock | 8,987 | $6.12 | $55,000.44 |
DisclosureSEC source: 0001493152-20-006503 · ownership.xml · nonDerivative · entry 1 Tenaerts Pamela · CIK 0001794913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,987 F1 · shares: Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2020 and January 1 and April 1, 2021, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d). F2 · price: Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 18:44 UTC | Scienture Holdings, Inc. MEDS · Entity 7802 | GrantStock Option · Derivative | 16,667 | Not disclosed Strike: $7.50 | Not disclosed |
DisclosureSEC source: 0001493152-20-005683 · ownership.xml · derivative · entry 1 Tenaerts Pamela · CIK 0001794913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires 2029-11-19 F2 · price: Granted in consideration for service on the Board of Directors. Granted under the Issuer's 2019 Equity Incentive Plan. Exempt pursuant to Rule 16b3(d). F1 · derivative.exercise_date: Options vest at the rate of 6.25% of such options per quarter (beginning November 19, 2019) for four years, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.